BT
Therapeutic Areas
Solu Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| STX-0712 | Chronic Myelomonocytic Leukemia (CMML) | Phase 1 |
| STX-1911 | Oncology (Novel Targeting) | Discovery |
| STX-0812 | Inflammatory Disease | Preclinical |
| STX-0640 | Systemic Mastocytosis and Immunoderm Indications | Preclinical |
| Na ion channel TicTACs | Pain | Preclinical |